title: Intensive immunotherapy with recombinant IL2 after autologous bone marrow transplantation is associated with a high incidence of bacterial infections.
authors.forename: D
authors.initials: D
authors.lastname: Blaise
authors.forename: A M
authors.initials: AM
authors.lastname: Stoppa
authors.forename: P
authors.initials: P
authors.lastname: Viens
authors.forename: D
authors.initials: D
authors.lastname: Sainty
authors.forename: C
authors.initials: C
authors.lastname: Fossat
authors.forename: M
authors.initials: M
authors.lastname: Miquel
authors.forename: D
authors.initials: D
authors.lastname: Olive
authors.forename: R
authors.initials: R
authors.lastname: Bouabdallah
authors.forename: J
authors.initials: J
authors.lastname: Gabert
authors.forename: D
authors.initials: D
authors.lastname: Baume
mesh_terms: D001424:Bacterial Infections / Q000209:etiology*; D016026:Bone Marrow Transplantation / Q000009:adverse effects; D006801:Humans; D007376:Interleukin-2 / Q000009:adverse effects*; D009369:Neoplasms / Q000628:therapy
chemical_list: D007376:Interleukin-2